Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Prostate Cancer

  Free Subscription

Articles published in Acta Radiol

Retrieve available abstracts of 13 articles:
HTML format

Single Articles

    July 2022
  1. STEVENS WM, Parchment-Smith C, Melling PP, Smith JT, et al
    Making an art into a science: a mathematical "Likert tool" can change PI-RADS (v2) scores into Likert scores when reporting multiparametric MRI for prostate cancer.
    Acta Radiol. 2022 Jul 11:2841851221112194. doi: 10.1177/02841851221112194.
    PubMed     Abstract available

    June 2022
  2. MAKELA P, Wright C, Anttinen M, Bostrom PJ, et al
    Safety and efficacy of MRI-guided transurethral ultrasound ablation for radiorecurrent prostate cancer in the presence of gold fiducial markers.
    Acta Radiol. 2022 Jun 24:2841851221108292. doi: 10.1177/02841851221108292.
    PubMed     Abstract available

  3. LEBOVICI A, Csutak C, Popa P, Crisan N, et al
    Magnetic resonance imaging characteristics of chronic prostatitis in patients under the age of 50: is it more than the eye can see?
    Acta Radiol. 2022;63:839-846.
    PubMed     Abstract available

    April 2022
  4. CHUNG JH, Park BK
    Transrectal ultrasound features and biopsy outcomes of transition PI-RADS 5.
    Acta Radiol. 2022;63:559-565.
    PubMed     Abstract available

    February 2022
  5. PARK SB
    Quantitative relaxation maps from synthetic MRI for prostate cancer.
    Acta Radiol. 2022 Feb 24:2841851221077405. doi: 10.1177/02841851221077405.

    September 2021
    International Scientific Prize.
    Acta Radiol. 2021;62:1131.

    June 2021
  7. LINHARES MOREIRA AS, De Visschere P, Van Praet C, Villeirs G, et al
    How does PI-RADS v2.1 impact patient classification? A head-to-head comparison between PI-RADS v2.0 and v2.1.
    Acta Radiol. 2021;62:839-847.
    PubMed     Abstract available

    November 2020
  8. MAKELA P, Anttinen M, Suomi V, Steiner A, et al
    Acute and subacute prostate MRI findings after MRI-guided transurethral ultrasound ablation of prostate cancer.
    Acta Radiol. 2020 Nov 28:284185120976931. doi: 10.1177/0284185120976931.
    PubMed     Abstract available

    September 2020
  9. YANG L, Tan Y, Dan H, Hu L, et al
    Diagnostic performance of diffusion-weighted imaging combined with dynamic contrast-enhanced magnetic resonance imaging for prostate cancer: a systematic review and meta-analysis.
    Acta Radiol. 2020 Sep 9:284185120956269. doi: 10.1177/0284185120956269.
    PubMed     Abstract available

    August 2020
  10. KIM SH
    Determination of Gleason score discrepancy for risk stratification in magnetic resonance-ultrasound fusion prostate biopsy.
    Acta Radiol. 2020;61:1134-1142.
    PubMed     Abstract available

    July 2020
  11. GIANNARINI G, Cereser L, Como G, Bonato F, et al
    Accuracy of abbreviated multiparametric MRI-derived protocols in predicting local staging of prostate cancer in men undergoing radical prostatectomy.
    Acta Radiol. 2020 Jul 27:284185120943047. doi: 10.1177/0284185120943047.
    PubMed     Abstract available

  12. QUEIROZ MR, Falsarella PM, Moreira Valle LG, Cayres Mariotti G, et al
    Is a sampling transition zone important to increase the detection of prostate cancer in systematic prostatic biopsies?
    Acta Radiol. 2020 Jul 6:284185120938363. doi: 10.1177/0284185120938363.
    PubMed     Abstract available

    April 2020
  13. SHAISH H, Casals R, Ahmed F, Makkar J, et al
    Impact of mandated prospectively reported apparent diffusion coefficient values on the rates of positivity for clinically significant prostate cancer by PI-RADS score.
    Acta Radiol. 2020 Apr 20:284185120915617. doi: 10.1177/0284185120915617.

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.